| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.06 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |